Teams

Sector
Stage
  • GeneVentiv Therapeutics, Inc.
    from University of North Carolina at Chapel Hill.

    GeneVentiv's AAV8.FVa gene therapy is the first universal gene therapy for all hemophilias and the first to treat inhibitor patients.

    Read More
  • Orion Therapeutics
    from UT Knoxville.

    Orion Therapeutics is a delivery platform-enabled RNA therapeutics company. We pair a proprietary lipid nanoparticle GENESYS™ delivery platform that entirely excludes ionizable cationic lipids with a vascular RNA therapy pipeline. Our safe,…

    Read More
  • Verdant Scientific, Inc.
    from Emory University.

    Verdant Scientific is developing a first-in-class, first-in-approach small molecule for the treatment of atopic dermatitis, more commonly known as eczema, which is poised to completely change the treatment of this chronic, inflammatory skin…

    Read More
  • VivoSphere LLC
    from Auburn University.

    Parasight System Inc. has developed and manufactures a veterinary diagnostic analyzer that combines antigen-based fluorescence detection with advanced AI-powered image recognition technology, delivering highly accurate and efficient analysis for…

    Read More